ABSTRACT
Children undergoing chemotherapy, hematopoietic stem cell transplantation, and solid organ transplantation are at high risk of acquiring invasive fungal infections (IFIs) due to the effects of immunosuppressive therapy. [1] [2] [3] [4] Mortality in children with IFI in these circumstances has been reported as high as 50%. [1] [2] [3] [4] In adults with IFI, early surgical debridement of infected tissue and timely administration of targeted antifungal therapy have been strongly associated with superior outcomes. [5] [6] [7] [8] Timely intervention, in turn, requires rapid diagnosis of IFI and sufficient taxonomic information about the offending fungus to guide antifungal therapy. Histologic examination of infected tissue is currently the swiftest diagnostic modality available. While fungal culture is commonly performed in tandem with histology, the fungal growth and sporulation required for fungal identification may require days to weeks. In addition, the sensitivity of culture is only 50% to 60%. 9 Upon completion of this activity you will be able to:
• describe strengths and weaknesses related to fungal culture, histology, and molecular testing of tissue biopsy specimens for the diagnosis of invasive fungal disease.
• list possible reasons why hyphae may be seen on tissue histology but fungal culture fails to grow organism.
• summarize the impact that histology findings on tissue may have on the care of patients with invasive fungal disease.
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Direct testing of tissue with various molecular assays has also been described, but turnaround time can vary depending on laboratory workflow. 9, 10 Finally, while data supporting the use of fungal biomarkers such as galactomannan and b-D-glucan for diagnosis of IFI have emerged in the adult literature, data remain sparse in children. 11 This study had two objectives. First, we evaluated the ability of histologic examination to predict results of fungal culture in immunocompromised children with IFI to determine if histology results can be relied on for clinical decision making. Second, we investigated the clinical impact of histologic results on the clinical care of children with IFI.
Materials and Methods
This study was approved by the institutional review board at The Children's Hospital of Philadelphia. The laboratory information system in the Department of Pathology and Laboratory Medicine at The Children's Hospital of Philadelphia was queried to identify all surgical pathology specimens that reported evidence of IFI between January 1, 2001, and December 31, 2012, inclusive. Patients were included if they met published histologic criteria for "proven" IFI. 12 Patients with evidence of yeast or hyphae in superficial skin and gastrointestinal biopsy specimens were excluded, as were autopsy specimens and specimens from patients with a documented history of IFI.
Data pertaining to patient age, sex, preoperative diagnosis, intraoperative findings, specimen source, and histologic findings were abstracted from surgical pathology reports. Primary and secondary diagnoses, immunosuppressive therapy, antifungal therapy, and operative records were abstracted from electronic medical records.
In the clinical microbiology laboratory, specimens were minced (not ground), and pieces were carefully pressed into agar that included inhibitory mold agar and Sabouraud dextrose agar. All cultures were incubated at 30°C in O 2 for 28 days.
In the surgical pathology facilities, specimens were processed, embedded in paraffin, sectioned at 4 µm, and stained with H&E for light microscopy. Specimens that were evaluated by frozen section were fixed in Polarstat LVF Frozen Section Medium (StatLab Medical Products, McKinney, TX), sectioned at 4 µm, and stained with H&E. In addition, all tissue specimens were histochemically stained with either the periodic acid-Schiff technique or Grocott's modification of Gomori's methenamine silver (GMS) method for the detection of microorganisms. All available histology slides were reviewed by two surgical pathologists (F.D. and T.R.B.) and a clinical microbiologist (K.V.S.) who were blinded to all other patient information but were not blinded to each other. Descriptions of fungal forms (eg, budding yeast, hyphae, pseudohyphae, and their morphologic features), granulomata, and tissue necrosis were recorded.
Concordance between histology and fungal culture was defined as documentation of budding yeast and/or pseudohyphae on histology and growth of a yeast isolate in culture, septate hyphae on histology and growth of a hyaline or dematiaceous septated mold in culture, and broad aseptate hyphae on histology and growth of a mucoraceous fungus (Mucorales) in culture.
Results
We initially identified 102 relevant specimens. Final pathology reports were located for all specimens. Forty-one specimens from patients with a documented history of IFI were excluded. Following review of medical records, 14 additional patients were excluded due to a lack of documented immunodeficiency. Forty-seven patients with IFI therefore remained for analysis. Ages ranged from 4 months to 24 years. Three patients were older than 18 years. Sixty-six percent were male, and 35 patients were undergoing immunosuppressive chemotherapy for an oncologic condition at the time of diagnosis. Diagnoses included standard and highrisk acute lymphoblastic leukemia, acute myeloid leukemia, lymphoma, and a variety of solid tumors. Six patients had recently undergone hematopoietic stem cell transplantation (HSCT), three had undergone solid organ transplantation, and one patient had undergone both liver transplant and HSCT. Two patients had underlying chronic granulomatous disease. Fourteen (30%) patients died within 12 months of IFI diagnosis. Seventeen (36%) were deceased at the time of case review. All of the deceased died before 18 years of age.
As summarized in ❚Table 1❚, the tissue specimens from the 47 patients were obtained from deep subcutaneous tissue (n = 21), visceral organs (14 lungs, five livers, and one spleen), and the sinonasal cavity (n = 6). Frozen sections were performed on 10 (21%) of the 47 specimens. Nine of the 10 frozen sections reported "fungal hyphae," "branching hyphae," "septate hyphae," "fungal element," or "fungal infection." In one case, the comment was, "No fungus seen." None of the 10 frozen section reports attempted more detailed descriptions of fungal morphology. The median time intervals between specimen receipt and reporting of the presence of fungal hyphae on frozen section and permanent stains were 19.9 minutes and 48 hours, respectively. Following blinded review, using consensus, the review team concurred with the original diagnosis in each of the 47 tissue specimens examined.
A specimen was concurrently submitted to the clinical microbiology laboratory for fungal culture in 40 (85%) of the 47 patients. Fungal culture grew a fungal isolate in 27 (68%) of the 40 patients, as summarized in Table 1 . All histology results (frozen and permanent sections), with the exception of one specimen, were concordant with the fungus grown in culture. In the remaining case, narrow septate hyphae with acute angle branching were seen abundantly and homogeneously on the GMS of a sinus biopsy specimen. The study review team concurred with this observation. However, both Fusarium species and Mucor species grew from culture. Among the 13 specimens with hyphae seen on histology but no growth on fungal cultures, nine had septate hyphae with acute angle branching; two had budding yeast; one had broad, aseptate hyphae; and one had severely distorted hyphae with septa.
In the seven cases in which fungal culture was not ordered, histology on a skin biopsy specimen and two sinonasal biopsy specimens showed septate hyphae with acute angle branching, a skin biopsy specimen showed broad aseptate hyphae, a liver biopsy specimen had budding yeast, and skin and sinonasal biopsy specimens showed distorted hyphae where hyphal morphology was difficult to discern. The median time interval between specimen receipt and reporting of the presence of fungal hyphae in culture was 3.9 days.
Complete medical records were available in 36 (77%) of the 47 patients. The antifungal therapy course for each of the 36 patients is summarized in ❚Table 2❚. Thirteen patients were not receiving antifungal therapy at the time of tissue acquisition, but therapy was initiated in all 13 following communication of histologic evidence of IFI. Availability of histology findings precipitated alterations in existing antifungal therapy in 10 (28%) of the 36 patients analyzed. Among the remaining 13 patients, histology did not prompt any change in antifungal therapy. Fifteen (42%) of the 36 patients underwent surgical excision of infected tissue, all within 48 hours.
Among the 27 patients in which fungal culture yielded a fungal isolate, fungal identification prompted alterations in antifungal therapy in 13 patients. An additional antifungal agent was added in two patients, the empiric antifungal agent was replaced by another agent in nine patients, and dual therapy was reduced to monotherapy in two. In the three of six patients with invasive candidiasis, fluconazole or caspofungin replaced an amphotericin B product, thereby discontinuing a nephrotoxic agent. In nine patients with invasive aspergillosis, voriconazole was initiated in four. The remaining five were already receiving voriconazole with or without caspofungin. All four patients with mucormycosis were receiving an amphotericin B product or posaconazole at the time of fungal identification in the microbiology laboratory.
Discussion
IFIs in our pediatric immunocompromised patient population had devastating consequences. This underscores the importance of early collaboration between clinicians, surgeons, pathologists, and microbiologists in the management of patients with suspected IFI. Specifically, opportunities for collaboration include early discussion between medical and surgical services when the suspicion of IFI is raised to ensure that frozen sections and fungal cultures are considered and requested. Subsequently, ongoing communication among the medical team, pathology, and clinical microbiology services allows prompt decision making around further surgical management and adjustments to antifungal therapy.
Our findings showed that histologic examination continues to play an important role in the early management of these patients. In most patients, actionable histology results became available before information from fungal cultures. Also, accuracy of histology compared with fungal culture was 100%, suggesting that histology in this context can be swift and is accurate. Performance of both frozen and permanent sections can be challenged, however, by the requirement that sufficient specimen volume be submitted to allow both modalities of testing. In one instance, Fusarium species and Mucor species grew in culture from a sinus biopsy specimen, but only narrow septate hyphae with acute angle branching were seen on the GMS. Fungal culture contamination with Mucor species is a possible explanation for this observation. Alternatively, two different anatomic areas of infected tissue may have been sampled. 13 In an extensive, adult-based, 10-year retrospective study, Sangoi et al 14 reported three instances in which mold with septate and dichotomously branching hyphae seen on histology were reported definitively but incorrectly with a diagnosis of invasive aspergillosis (fungal culture grew Scedosporium apiospermum in two patients and Fusarium species in the third). While we did not observe a similar practice in our pathology reports, we had six cases with similar histology findings in which Fusarium and various dematiaceous fungi were isolated. Care is clearly required when attempting genus-level diagnosis based on histologic findings. 14 Despite the fact that histology generally provides, at best, family-or group-level identification of an infecting fungus (ie, yeast vs mucoraceous mold vs hyaline/dematiaceous septated mold), communication of histology results led to alterations in antifungal therapy in more than half of all patients. The most critical cases were the 13 patients who were not receiving antifungal therapy prior to the communication of histology findings. This is relevant since animal models have suggested that therapeutic delay of as little as 48 to 72 hours following tissue inoculation can adversely affect outcomes in IFI. 15 Moreover, in 42% of patients, communication of histology results led to a request for a surgical consultation. Early surgical excision is documented to reduce morbidity and mortality. [5] [6] [7] [8] By contrast, the role of fungal culture seemed to focus on the fine tuning of antifungal therapy. Positive fungal culture results led to adjustment of antifungal therapy in 50% of patients based on identification at the genus/species level, suggesting that knowledge of the etiologic agent can support clinical decision making. These therapeutic adjustments are critical in the management of invasive fungal infections. For example, species-level identification allows clinicians to navigate species-specific antifungal resistance patterns and emerging antifungal resistance in Candida species. 16, 17 We also found that clinicians appropriately used growth of Aspergillus species as a cue to adjust antifungal therapy to ensure that voriconazole was administered. Voriconazole has been considered the preferred therapeutic agent for the treatment of invasive aspergillosis. 18, 19 In an era in which clinicians have multiple antifungal options to choose from, fungal identification has therefore become increasingly useful.
Unfortunately, the sensitivity of fungal culture in our cohort was only 68%, which is consistent with other similar reports. 9 Nine of the 13 biopsy specimens with hyphae present on histology and no growth of fungi had histologic findings that were consistent with hyaline or dematiaceous septated molds. Fontana-Masson staining is not regularly used in this context at our institution to distinguish hyaline from dematiaceous molds due to concerns about false-positive melanin staining. 20 In these instances, the fungus may have been nonviable, or normal tissue may have been inadvertently sampled and cultured. 13 Mucoraceous molds are © American Society for Clinical Pathology particularly delicate and prone to destruction if specimens are handled aggressively (eg, grinding, fine mincing) prior to culture. In our cohort, however, this did not appear to be a systematic problem. Three of the four specimens with broad, aseptate hyphae seen on histology grew Rhizopus species. Given the importance of fungal etiology in IFI management, molecular diagnostic methods are an option in this situation. Considerable efforts have been undertaken to standardize fungal detection by molecular methods, and recommendations have been published. 9, 10 This is clearly an area that continues to evolve. This study had a number of limitations. First, we considered fungal culture the "gold-standard" arbiter of the etiology of each episode of IFI. False-positive cultures due to specimen contamination are a theoretical possibility. Similarly, we did not evaluate episodes of IFI that were histology negative, culture positive. While published consensus criteria for "proven" IFI include either histologic evidence of hyphae or isolation of fungi in culture, we opted to restrict our study to histology-positive cases since our goal was to evaluate the performance and clinical impact of histology in pediatric IFI. 12 Second, we analyzed antifungal use as an aggregate over the 12-year study period. Antifungal use was evolving during the study period. 21 An analysis of antifungal use over time with a larger sample size would be beneficial. Third, fungal culture was not ordered in 15% of patients, possibly introducing sampling bias. Review of medical records did not yield a clear explanation for the omissions. We did note that parallel specimens were sent to the clinical microbiology laboratory for fungal culture in 10 of 10 cases in which frozen section was performed. The surgeons appeared to be thinking about the performance of frozen section in tandem with fungal culture. One possible approach to ensuring consistent ordering of fungal culture in suspected cases of IFI may therefore be to systematically link biopsy histology orders with requests for frozen section and fungal culture on requisition forms (or "order sets" in settings in which test orders are entered electronically).
In summary, histologic examination of tissue can be both rapid and accurate, and it provides clinically actionable information to clinicians who care for children with IFIs. Fungal culture still plays a critical role in the fine tuning of antifungal therapy. Molecular diagnostics may provide an adjunctive diagnostic modality when fungal culture fails to yield a pathogen.
